Expectancy for Adderall influences subjective mood and drug effects regardless of concurrent caffeine ingestion: A randomized controlled trial
ConclusionsExpectation for prescription stimulant effects influenced subjective outcomes in a sample of high-risk college students. These findings may inform expectancy challenge interventions to reduce NPS.Trial registrationClinicalTrials.gov Identifier: NCT03648684. (Source: Psychopharmacology)
Source: Psychopharmacology - September 23, 2023 Category: Psychiatry Source Type: research
Cigarette and e-cigarette use trajectories and prospective prescription psychotherapeutic drug misuse among adolescents and young adults
This study aimed to determine the potential longitudinal impact of different cigarette and e-cigarette use trajectories among people aged 10-24 on prescription drug misuse of psychotherapeutic drugs.METHODS: Data came from waves 1-5 of the Population Assessment of Tobacco and Health (PATH) Study (2013-2019; n = 14,454). Group-based trajectory modeling identified groups of adolescents and young adults based on cigarette and e-cigarette use across the five waves. Weighted logistic regression models were fit to examine the association of group membership with two outcomes at all waves: 1) misuse of opioids, sedatives, and/or ...
Source: Addictive Behaviors - August 4, 2023 Category: Addiction Authors: Moriah R Harton Dong-Chul Seo Rebecca J Evans-Polce Ivana Nguyen Maria A Parker Source Type: research
Cigarette and e-cigarette use trajectories and prospective prescription psychotherapeutic drug misuse among adolescents and young adults
This study aimed to determine the potential longitudinal impact of different cigarette and e-cigarette use trajectories among people aged 10-24 on prescription drug misuse of psychotherapeutic drugs.METHODS: Data came from waves 1-5 of the Population Assessment of Tobacco and Health (PATH) Study (2013-2019; n = 14,454). Group-based trajectory modeling identified groups of adolescents and young adults based on cigarette and e-cigarette use across the five waves. Weighted logistic regression models were fit to examine the association of group membership with two outcomes at all waves: 1) misuse of opioids, sedatives, and/or ...
Source: Addictive Behaviors - August 4, 2023 Category: Addiction Authors: Moriah R Harton Dong-Chul Seo Rebecca J Evans-Polce Ivana Nguyen Maria A Parker Source Type: research
DEA Delays Proposed Telehealth, Buprenorphine Rules
The U.S. Drug Enforcement Administration (DEA)has delayed finalizing two proposed rules that were set to go into effect after theCOVID-19 public health emergency expires on May 11. The proposed rules, if finalized, would affect how health professionals implement telehealth services and prescribe certain controlled medications, including medications for treating attention-deficit/hyperactivity disorder and opioid use disorder (OUD). The DEA received 38,000 comments in response to the proposed rules, which wereannounced on February 24. Instead of finalizing the rules, the DEA, in concert with the U.S. Department of Health an...
Source: Psychiatr News - May 4, 2023 Category: Psychiatry Tags: Anne Milgram APA controlled substances DEA Department of Health and Human Services Drug Enforcement Administration opioid use disorder telehealth Source Type: research
APA Responds to DEA ’s Proposed Rules Regarding Telehealth, Buprenorphine
Today APA filed two letters with the U.S. Drug Enforcement Administration (DEA) in response to two proposed rules that if finalized would affect how health professionals implement telehealth services and prescribe certain controlled medications. The proposed rules, which were developed with the U.S. Department of Health and Human Services and in close coordination with the U.S. Department of Veterans Affairs andannounced on February 24, would extend certain flexibilities in these areas after the COVID-19 public health emergency expires on May 11. Yet in several ways the proposed rules are more restrictive than what the pub...
Source: Psychiatr News - March 31, 2023 Category: Psychiatry Tags: APA barriers to care buprenorphine controlled substances costs DEA opioid use disorder proposed rule public health emergency telehealth Source Type: research
New U.S. law promises to light up marijuana research
It just got easier for U.S. scientists to get their hands on some pot—for research, that is.
President Joe Biden today signed into law a bill that streamlines access to marijuana for medical research.
The new law
is expected to speed the issuance of government permits to scientists who want to study cannabis, whose medicinal promise has been widely touted but remains, with a few exceptions, unproven. It will also expedite applications from producers—including universities—that want to grow and distribute the drug for research. It also obliges the federal government to make sure an adequate, uninterrup...
Source: Science of Aging Knowledge Environment - December 2, 2022 Category: Geriatrics Source Type: research
Amphetamine, Dextroamphetamine Mixed Salts-Associated Ischemic Colitis
No abstract available (Source: American Journal of Therapeutics)
Source: American Journal of Therapeutics - November 1, 2022 Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research
A Student Walks into Class … Vignettes to Identify Substance Use Disorder Models of Illness among College Students
CONCLUSIONS: Illness recognition and perceived severity varied across substances and were lowest for cannabis. Few participants conceptualized SUDs as chronic medical conditions. College students may benefit from psychoeducation regarding cannabis use disorder and the chronic medical condition model of SUDs.PMID:35787230 | DOI:10.1080/10826084.2022.2091787 (Source: Substance Use and Misuse)
Source: Substance Use and Misuse - July 5, 2022 Category: Addiction Authors: Declan T Barry David E Oberleitner Mark Beitel Lindsay M S Oberleitner Marina Gaeta Gazzola Anthony Eller Lynn M Madden Xiaoying Zheng Emma Bergman Joseph F Tamberelli Source Type: research
Websites Selling Controlled Drugs Without a Prescription
The FDA and the US Drug Enforcement Administration (DEA) recently issued joint warning letters to the operators of 2 websites illegally selling amphetamine drug products marketed as Adderall, a Schedule II stimulant, without a prescription. (Source: JAMA)
Source: JAMA - May 17, 2022 Category: General Medicine Source Type: research
The effect of methylphenidate and mixed amphetamine salts on cognitive reflection: a field study
ConclusionsThe results indicate that MPH enhances decision-making in tasks where heuristic responses typically bias it. (Source: Psychopharmacology)
Source: Psychopharmacology - November 2, 2021 Category: Psychiatry Source Type: research
Investigating sex differences and the effect of drug exposure order in the sensory reward-enhancing effects of nicotine and d-amphetamine alone and in combination
Neuropharmacology. 2021 Oct 19:108845. doi: 10.1016/j.neuropharm.2021.108845. Online ahead of print.ABSTRACTNicotine enhances the rewarding effects of other environmental stimuli; this reward-enhancement encourages and maintains nicotine consumption. Nicotine use precedes other psychostimulant use, but receiving a stimulant prescription also predicts future smoking. Previously, no study has investigated effects of drug exposure order in reward-enhancement, nor with nicotine and d-amphetamine. Thus, we aimed to investigate how drug exposure order impacted the reward-enhancing effects of nicotine and d-amphetamine, alone and...
Source: Neuropharmacology - October 22, 2021 Category: Drugs & Pharmacology Authors: Kathleen R McNealy Sydney D Houser Scott T Barrett Rick A Bevins Source Type: research
Association of Alopecia Areata With Attention-Deficit/Hyperactivity Disorder Stimulant Medication: A Case-Control Study
Conclusion: Although the sample size of cases with AU was small, we found a significant association between AU and ASM. While further study is needed, practitioners may consider close monitoring of patients with AA who use ASM for the development of worsening disease and discontinue the medication if the patient experiences an increase in hair loss that appears to be progressing to AU.PMID:34239372 | PMC:PMC8238113 | DOI:10.31486/toj.20.0025 (Source: Ochsner Journal)
Source: Ochsner Journal - July 9, 2021 Category: General Medicine Authors: Tyson A Meaux Pamela M McMahon Glenn N Jones Amelia E Bush Jaren J Kennedy George William Poche Source Type: research
